MAGENTA THERAPEUTICS INC (MGTA)

US55910K1088 - Common Stock

0.6996  -0.06 (-7.74%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
58.57M80.90M74.69M78.70M82.97M
Research and Development
35.13M55.14M46.77M50.62M59.21M
Selling, General, and Administrative Expenses
23.44M25.76M27.93M28.09M23.76M
Operating Income
-58.57M-80.90M-74.69M-78.70M-82.97M
Interest Income/Expense
9.79M4.44M3.56M3.77M6.20M
Income Before Taxes
-68.69M-76.46M-71.14M-74.94M-76.77M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-68.69M-76.46M-71.14M-74.94M-76.77M
EBITDA
N/A-78.98M-72.67M-76.72M-81.13M
 
Per Share Data
EPS Diluted Total Ops
-14.16-1.29-1.29-1.71-33.18
Non GAAP EPS
-1.14-1.29-1.31-1.74-2.05
 
Statistics

All data in USD

Charts